Environmental toxicants and autism spectrum disorders: A systematic review

Translational Psychiatry

Volumn 4, Issue 2, 2014, Pages

  Rossignol, D A ^a   Genuis, S J ^b   Frye, R E ^c  

^a Rossignol Medical Center   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

Autism; environmental medicine; Gene environment interaction; Heavy metals; Polymorphisms; Toxicants

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALUMINUM; ARSENIC; ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; CADMIUM; FERROPORTIN 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; HEAVY METAL; LEAD; METHYLMERCURY; NICKEL; PESTICIDE; PHTHALIC ACID DERIVATIVE; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; SOLVENT; TIN; TOXIC SUBSTANCE; URANIUM; DANGEROUS GOODS;

AIR POLLUTANT; AIR POLLUTION; AUTISM; BLOOD LEVEL; BRAIN LEVEL; CHILDHOOD; DISEASE SEVERITY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HAIR LEVEL; HAZARDOUS WASTE SITE; HEREDITY; HUMAN; NERVE CELL DIFFERENTIATION; POLLUTANT; PREGNANCY; REVIEW; SYSTEMATIC REVIEW; TISSUE LEVEL; TOOTH LEVEL; URINE LEVEL; WATER POLLUTANT; CHEMICALLY INDUCED; DANGEROUS GOODS; GENETICS; TOXICITY;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENE-ENVIRONMENT INTERACTION; HAZARDOUS SUBSTANCES; HUMANS;

EID: 84908395017     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.4     Document Type: Review

References (214)

1. APA. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Association: Washington, DC, USA, 1994.
2. Baio J. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012; 61: 1-19.
3. Rice C. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR 2007; 56: 12-28.
4. Schaefer GB, Mendelsohn NJ. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med 2013; 15: 399-407.
5. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011; 68: 1095-1102.
6. Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 2012; 17: 389-401.
7. Ming X, Brimacombe M, Chaaban J, Zimmerman-Bier B, Wagner GC. Autism spectrum disorders: concurrent clinical disorders. J Child Neurol 2008; 23: 6-13.
8. Herbert MR. Autism: a brain disorder or a disorder that affects the brain. Clin Neuropsychiatry 2005; 2: 354-379.
9. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006; 368: 2167-2178.
10. Goldman LR, Koduru S. Chemicals in the environment and developmental toxicity to children: a public health and policy perspective. Environ Health Perspect 2000; 108: 443-448.
11. Grandjean P, Perez M. Development neurotoxicity: implications of methylmercury research. Int J Environ Health 2008; 2: 417-428.
12. Faustman EM, Silbernagel SM, Fenske RA, Burbacher TM, Ponce RA. Mechanisms underlying Children's susceptibility to environmental toxicants. Environ Health Perspect 2000; 108: 13-21.
13. Lawler CP, Croen LA, Grether JK. Van de Water J. Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev 2004; 10: 292-302.
14. Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG et al. Autism and environmental genomics. Neurotoxicology 2006; 27: 671-684.
15. Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ et al. Pattern of sequence variation across 213 environmental response genes. Genome Res 2004; 14: 1821-1831.
16. Lawler CP. The 'environment' for autism research: signs of improvement? Environ Health Perspect 2008; 116: A416-A417.
17. Cheslack-Postava K, Rantakokko PV, Hinkka-Yli-Salomaki S, Surcel HM, McKeague IW, Kiviranta HA et al. Maternal serum persistent organic pollutants in the Finnish Prenatal Study of Autism: a pilot study. Neurotoxicol Teratol 2013; 38: 1-5.
18. Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB, Johnson C et al. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 2007; 115: 792-798.
19. Miodovnik A, Engel SM, Zhu C, Ye X, Soorya LV, Silva MJ et al. Endocrine disruptors and childhood social impairment. Neurotoxicology 2011; 32: 261-267.
20. Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, Barr DB et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006; 118: e1845-e1859.
21. van Wijngaarden E, Davidson PW, Smith TH, Evans K, Yost K, Love T et al. Autism spectrum disorder phenotypes and prenatal exposure to methylmercury. Epidemiology 2013; 24: 651-659.
22. Coleman M. The Autistic Syndromes. North-Holland Publishing: New York, NY, USA, 1976.
23. Felicetti T. Parents of autistic children: some notes on a chemical connection. Milieu Ther 1981; 1: 13-16.
24. McCanlies EC, Fekedulegn D, Mnatsakanova A, Burchfiel CM, Sanderson WT, Charles LE et al. Parental occupational exposures and autism spectrum disorder. J Autism Dev Disord 2012; 42: 2323-2334.
25. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007; 115: 1482-1489.
26. Roberts EM, English PB. Bayesian modeling of time-dependent vulnerability to environmental hazards: an example using autism and pesticide data. Stat Med 2013; 32: 2308-2319.
27. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect 2011; 119: 873-877.
28. Kalkbrenner AE, Daniels JL, Chen JC, Poole C, Emch M, Morrissey J. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 2010; 21: 631-641.
29. Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B. Ambient air pollution and autism in Los Angeles County, California. Environ Health Perspect 2012; 121: 380-386.
30. Volk HE, Lurmann F, Penfold B, Hertz-Picciotta I, McConnell R. Traffic-related air pollution, particulate matter, and autism. Arch Gen Psychiatry 2012; 1-7.
31. Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF et al. Perinatal air pollutant exposures and autism spectrum disorder in the children of nurses' health study II participants. Environ Health Perspect 2013; 121: 978-984.
32. Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB. Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology 2013; 25: 44-47.
33. Kim SM, Han DH, Lyoo HS, Min KJ, Kim KH, Renshaw P. Exposure to environmental toxins in mothers of children with autism spectrum disorder. Psychiatry Investig 2010; 7: 122-127.
34. Windham GC, Sumner A, Li SX, Anderson M, Katz E, Croen LA et al. Use of birth certificates to examine maternal occupational exposures and autism spectrum disorders in offspring. Autism Res 2013; 6: 57-63.
35. Pino-Lopez M, Romero-Ayuso DM. Parental occupational exposures and autism spectrum disorder in children. Rev Esp Salud Publica 2013; 87: 73-85.
36. Garry VF, Harkins ME, Erickson LL, Long-Simpson LK, Holland SE, Burroughs BL. Birth defects, season of conception, and sex of children born to pesticide applicators living in the Red River Valley of Minnesota, USA. Environ Health Perspect 2002; 110: 441-449.
37. Audouze K, Grandjean P. Application of computational systems biology to explore environmental toxicity hazards. Environ Health Perspect 2011; 119: 1754-1759.
38. Ming X, Brimacombe M, Malek JH, Jani N, Wagner GC. Autism spectrum disorders and identified toxic land fills: co-occurrence across States. Environ Health Insights 2008; 2: 55-59.
39. Desoto MC. Ockman's razor and autism: the case for developmental neurotoxins contributing to a disease of neurodevelopment. Neurotoxicology 2009; 30: 331-337.
40. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environ Health Perspect 2006; 114: 1438-1444.
41. Jung CR, Lin YT, Hwang BF. Air pollution and newly diagnostic autism spectrum disorders: a population-based cohort study in Taiwan. PLoS One 2013; 8: e75510.
42. Chang S, Crothers C, Lai S, Lamm S. Pediatric neurobehavioral diseases in Nevada counties with respect to perchlorate in drinking water: an ecological inquiry. Birth Defects Res A Clin Mol Teratol 2003; 67: 886-892.
43. ATSDR. 2000 Division of Health Assessment and Consultation. Public Health Assessment, Brick Township Investigation, Appendix A - Contaminants of Concern. Available at http://www.atsdr.cdc.gov/hac/pha/pha.asp?docid=380&pg=0 (accessed 2 November 2013).
44. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 2006; 12: 203-209.
45. Bartell SM, Lewandowski TA. Administrative censoring in ecological analyses of autism and a Bayesian solution. J Environ Public Health 2011; 2011: 202783.
46. Lewandowski TA, Bartell SM, Yager JW, Levin L. An evaluation of surrogate chemical exposure measures and autism prevalence in Texas. J Toxicol Environ Health A 2009; 72: 1592-1603.
47. Palmer RF, Blanchard S, Wood R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009; 15: 18-24.
48. Blanchard KS, Palmer RF, Stein Z. The value of ecologic studies: mercury concentration in ambient air and the risk of autism. Rev Environ Health 2011; 26: 111-118.
49. Schweikert C, Li Y, Dayya D, Yens D, Torrents M, Hsu DF. Analysis of autism prevalence and neurotoxins using combinatorial fusion and association rule mining. Ninth IEEE International Conference on Bioinformatics and Bioengineering 2009, 400-404.
50. Rury J. Links between environmental mercury, special education, and autism in Louisiana. 2008 thesis, Louisiana State University: Baton Rouge, LA, USA, 2006.
51. DeSoto MC, Hitlan RT. Fish consumption advisories and the surprising relationship to prevalence rate of developmental disability as reported by public schools. J Environ Prot 2012; 3: 1579-1589.
52. Chrysochoou C, Rutishauser C, Rauber-Luthy C, Neuhaus T, Boltshauser E, Superti-Furga A. An 11-month-old boy with psychomotor regression and autoaggressive behaviour. Eur J Pediatr 2003; 162: 559-561.
53. Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010; 126: 656-664.
54. Larsson M, Weiss B, Janson S, Sundell J, Bornehag CG. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8 years of age. Neurotoxicology 2009; 30: 822-831.
55. Ip P, Wong V, Ho M, Lee J, Wong W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol 2004; 19: 431-434.
56. Desoto MC, Hitlan RT. Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol 2007; 22: 1308-1311.
57. Geier DA, Audhya T, Kern JK, Geier MR. Blood mercury levels in autism spectrum disorder: is there a threshold level? Acta Neurobiol Exp (Wars) 2010; 70: 177-186.
58. Albizzati A, More L, Di Candia D, Saccani M, Lenti C. Normal concentrations of heavy metals in autistic spectrum disorders. Minerva Pediatr 2012; 64: 27-31.
59. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E et al. Toxicological status of children with autism vs neurotypical children and the association with autism severity. Biol Trace Elem Res 2013; 151: 171-180.
60. Rahbar MH, Samms-Vaughan M, Loveland KA, Ardjomand-Hessabi M, Chen Z, Bressler J et al. Seafood consumption and blood mercury concentrations in Jamaican children with and without autism spectrum disorders. Neurotox Res 2013; 23: 22-38.
61. Stamova B, Green PG, Tian Y, Hertz-Picciotto I, Pessah IN, Hansen R et al. Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res 2011; 19: 31-48.
62. Hertz-Picciotto I, Green PG, Delwiche L, Hansen R, Walker C, Pessah IN. Blood mercury concentrations in CHARGE Study children with and without autism. Environ Health Perspect 2010; 118: 161-166.
63. Blaurock-Busch E, Amin OR, Rabah T. Heavy metals and trace elements in hair and urine of a sample of Arab children with autistic spectrum disorder. Maedica (Buchar) 2011; 6: 247-257.
64. Wright B, Pearce H, Allgar V, Miles J, Whitton C, Leon I et al. A comparison of urinary mercury between children with autism spectrum disorders and control children. PLoS One 2012; 7: e29547.
65. Bradstreet JJ, Geier DA, Kartzinel JJ, Adams JB, Geier MR. A case-control study of mercury burden in children with autistic spectrum disorders. J Amer Physicians Surg 2003; 8: 76-79.
66. Soden SE, Lowry JA, Garrison CB, Wasserman GS. 24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study. Clin Toxicol (Phila) 2007; 45: 476-481.
67. Blaucok-Busch E, Amin OR, Dessoki HH, Rabah T. Efficacy of DMSA therapy in a sample of Arab children with autistic spectrum disorder. Maedica (Buchar) 2012; 7: 214-221.
68. Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM et al. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 1995; 97: 23-38.
69. Fido A, Al-Saad S. Toxic trace elements in the hair of children with autism. Autism 2005; 9: 290-298.
70. Al-Ayadhi LY. Heavy metals and trace elements in hair samples of autistic children in central Saudi Arabia. Neurosciences (Riyadh) 2005; 10: 213-218.
71. El-Baz F, Elhossiny RM, Elsayed AB, Gaber GM. Hair mercury measurement in Egyptian autistic children. Egypt J Med Hum Genet 2010; 11: 135-141.
72. Elsheshtawy E, Tobar S, Sherra K, Atallah S, Elkasaby R. Study of some biomarkers in hair of children with autism. Middle East Curr Psychiatry 2011; 18: 6-10.
73. Lakshmi Priya MD, Geetha A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res 2011; 142: 148-158.
74. Blaurock-Busch E, Amin OR, Dessoki HH, Rabah T. Toxic metals and essential elements in hair and severity of symptoms among children with autism. Maedica (Buchar) 2012; 7: 38-48.
75. Majewska MD, Urbanowicz E, Rok-Bujko P, Namyslowska I, Mierzejewski P. Agedependent lower or higher levels of hair mercury in autistic children than in healthy controls. Acta Neurobiol Exp (Wars) 2010; 70: 196-208.
76. Yasuda H, Yasuda Y, Tsutsui T. Estimation of autistic children by metallomics analysis. Sci Rep 2013; 3: 1199.
77. Adams JB, Romdalvik J, Levine KE, Hu L-W. Mercury in first-cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 2008; 1-14.
78. Adams JB, Holloway CE, George F, Quig D. Analyses of toxic metals and essential minerals in the hair of Arizona children with autism and associated conditions, and their mothers. Biol Trace Elem Res 2006; 110: 193-209.
79. Wecker L, Miller SB, Cochran SR, Dugger DL, Johnson WD. Trace element concentrations in hair from autistic children. J Ment Defic Res 1985; 29, Pt 1 15-22.
80. Williams PG, Hersh JH, Allard A, Sears LL. A controlled study of mercury levels in hair samples of children with autism as compared to their typically developing siblings. Res Autism Spect Disord 2008; 2: 170-175.
81. De Palma G, Catalani S, Franco A, Brighenti M, Apostoli P. Lack of correlation between metallic elements analyzed in hair by ICP-MS and autism. J Autism Dev Disord 2012; 42: 342-353.
82. Kern JK, Grannemann BD, Trivedi MH, Adams JB. Sulfhydryl-reactive metals in autism. J Toxicol Environ Health A 2007; 70: 715-721.
83. Obrenovich ME, Shamberger RJ, Lonsdale D. Altered heavy metals and transketolase found in autistic spectrum disorder. Biol Trace Elem Res 2011; 144: 475-486.
84. Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 2003; 22: 277-285.
85. Canuel R, de Grosbois SB, Atikesse L, Lucotte M, Arp P, Ritchie C et al. New evidence on variations of human body burden of methylmercury from fish consumption. Environ Health Perspect 2006; 114: 302-306.
86. Adams JB, Romdalvik J, Ramanujam VM, Legator MS. Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health A 2007; 70: 1046-1051.
87. Rinderknecht AL, Kleinman MT, Ericson JE. Pb enamel biomarker: deposition of pre- and postnatal Pb isotope injection in reconstructed time points along rat enamel transect. Environ Res 2005; 99: 169-176.
88. Abdullah MM, Ly AR, Goldberg WA, Clarke-Stewart KA, Dudgeon JV, Mull CG et al. Heavy metal in children's tooth enamel: related to autism and disruptive behaviors? J Autism Dev Disord 2012; 42: 929-936.
89. Sajdel-Sulkowska EM, Lipinski B, Windom H, Audhya T, McGinnis WR. Oxidative stress in autism: elevated cerebellar 3-nitrotyrosine levels. Am J Biochem Biotech 2008; 4: 73-84.
90. Shandley K, Austin DW. Ancestry of pink disease (infantile acrodynia) identified as a risk factor for autism spectrum disorders. J Toxicol Environ Health A 2011; 74: 1185-1194.
91. Accardo P, Whitman B, Caul J, Rolfe U. Autism and plumbism. A possible association. Clin Pediatr (Phila) 1988; 27: 41-44.
92. Eppright TD, Sanfacon JA, Horwitz EA. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. Mo Med 1996; 93: 136-138.
93. Lidsky TI, Schneider JS. Autism and autistic symptoms associated with childhood lead poisoning. J Appl Res 2005; 5: 80-87.
94. Newton KE, Leonard M, Delves HT, Bowen-Jones D. A problem with her lead weight. Ann Clin Biochem 2005; 42: 145-148.
95. Shannon M, Graef JW. Lead intoxication in children with pervasive developmental disorders. J Toxicol Clin Toxicol 1996; 34: 177-181.
96. George M, Heeney MM, Woolf AD. Encephalopathy from lead poisoning masquerading as a flu-like syndrome in an autistic child. Pediatr Emerg Care 2010; 26: 370-373.
97. Hallaway N. From autistic to lead toxic. Can Nurse 1993; 89: 53-54.
98. Campbell M, Petti TA, Green WH, Cohen IL, Genieser NB, David R. Some physical parameters of young autistic children. J Am Acad Child Psychiatry 1980; 19: 193-212.
99. Clark B, Vandermeer B, Simonetti A, Buka I. Is lead a concern in Canadian autistic children? Paediatr Child Health 2010; 15: 17-22.
100. Cohen DJ, Johnson WT, Caparulo BK. Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child 1976; 130: 47-48.
101. El-Ansary A, Al-Daihan S, Al-Dbass A, Al-Ayadhi L. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clin Biochem 2010; 43: 63-70.
102. El-Ansary AK, Bacha AB, Ayahdi LY. Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia. Clin Biochem 2011; 44: 1116-1120.
103. Cohen DJ, Paul R, Anderson GM, Harcherik DF. Blood lead in autistic children. Lancet 1982; 2: 94-95.
104. Tian Y, Green PG, Stamova B, Hertz-Picciotto I, Pessah IN, Hansen R et al. Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res 2011; 19: 1-13.
105. Vergani L, Cristina L, Paola R, Luisa AM, Shyti G, Edvige V et al. Metals, metallothioneins and oxidative stress in blood of autistic children. Res Autism Spect Disord 2011; 5: 286-293.
106. Yorbik O, Kurt I, Hasimi A, Ozturk O. Chromium, cadmium, and lead levels in urine of children with autism and typically developing controls. Biol Trace Elem Res 2010; 135: 10-15.
107. Al-Farsi YM, Waly MI, Al-Sharbati MM, Al-Shafaee MA, Al-Farsi OA, Al-Khaduri MM et al. Levels of heavy metals and essential minerals in hair samples of children with autism in Oman: a case-control study. Biol Trace Elem Res 2012; 151: 181-186.
108. Gentile PS, Trentalange MJ, Zamichek W, Coleman M. Brief report: trace elements in the hair of autistic and control children. J Autism Dev Disord 1983; 13: 205-206.
109. Shearer TR, Larson K, Neuschwander J, Gedney B. Minerals in the hair and nutrient intake of autistic children. J Autism Dev Disord 1982; 12: 25-34.
110. Rahbar MH, Samms-Vaughan M, Ardjomand-Hessabi M, Loveland KA, Dickerson AS, Chen Z et al. The role of drinking water sources, consumption of vegetables and seafood in relation to blood arsenic concentrations of Jamaican children with and without autism spectrum disorders. Sci Total Environ 2012; 433: 362-370.
111. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol 2009; 2009: 1-7.
112. Geier DA, Kern JK, King PG, Sykes LK, Geier MR. Hair toxic metal concentrations and autism spectrum disorder severity in young children. Int J Environ Res Public Health 2012; 9: 4486-4497.
113. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A--medical results. BMC Clin Pharmacol 2009; 9: 16.
114. Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol 2006; 214: 99-108.
115. Goin-Kochel RP, Mackintosh VH, Myers BJ. Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders. Res Autism Spect Disord 2009; 3: 528-537.
116. Patel K, Curtis LT. A comprehensive approach to treating autism and attentiondeficit hyperactivity disorder: a prepilot study. J Altern Complement Med 2007; 13: 1091-1097.
117. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol 2009; 9: 17.
118. Geier DA, Geier MR. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuro Endocrinol Lett 2006; 27: 833-838.
119. Kidd PM. Autism, an extreme challenge to integrative medicine. Part II: Medical management. Alternat Med Rev 2002; 7: 472-499.
120. Lonsdale D, Shamberger RJ, Audhya T. Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinol Lett 2002; 23: 303-308.
121. Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E. A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat 2012; 2012: 870391.
122. Woods JS. Porphyrin Metabolism as Indicator of Metal Exposure and Toxicity. vol. 115. Springer-Verlag: Berlin, 1995.
123. Heyer NJ, Bittner AC Jr, Echeverria D, Woods JS. A cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production. Toxicol Lett 2006; 161: 159-166.
124. Pingree SD, Simmonds PL, Rummel KT, Woods JS. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats. Toxicol Sci 2001; 61: 234-240.
125. Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P et al. Sodium 2, 3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther 1995; 272: 264-274.
126. Austin DW, Shandley K. An investigation of porphyrinuria in Australian children with autism. J Toxicol Environ Health A 2008; 71: 1349-1351.
127. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R et al. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 2009; 280: 101-108.
128. Geier DA, Kern JK, Geier MR. A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders. J Toxicol Environ Health A 2009; 72: 1585-1591.
129. Kern JK, Geier DA, Adams JB, Geier MR. A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder. Biometals 2010; 23: 1043-1051.
130. Geier DA, Geier MR. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res 2006; 10: 57-64.
131. Geier DA, Geier MR. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health A 2007; 70: 1723-1730.
132. Heyer NJ, Echeverria D, Woods JS. Disordered porphyrin metabolism: a potential biological marker for autism risk assessment. Autism Res 2012; 5: 84-92.
133. Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR. Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins. Pediatr Int 2011; 53: 147-153.
134. Woods JS, Armel SE, Fulton DI, Allen J, Wessels K, Simmonds PL et al. Urinary porphyrin excretion in neurotypical and autistic children. Environ Health Perspect 2010; 118: 1450-1457.
135. Youn SI, Jin SH, Kim SH, Lim S. Porphyrinuria in Korean children with autism: correlation with oxidative stress. J Toxicol Environ Health A 2010; 73: 701-710.
136. Frye RE, Rossignol DA. Mitochondrial physiology and autism spectrum disorder. OA Autism 2013; 1: 5.
137. Edelson SB, Cantor DS. Autism: xenobiotic influences. Toxicol Ind Health 1998; 14: 553-563.
138. Edelson SB, Cantor DS. The neurotoxic etiology of the autistic spectrum disorders: a replication study. Toxicol Ind Health 2000; 16: 239-247.
139. Otake T, Yoshinaga J, Seki Y, Matsumura T, Watanabe K, Ishijima M et al. Retrospective in utero exposure assessment of PCBs using preserved umbilical cords and its application to case-control comparison. Environ Health Prev Med 2006; 11: 65-68.
140. Mitchell MM, Woods R, Chi LH, Schmidt RJ, Pessah IN, Kostyniak PJ et al. Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ Mol Mutagen 2012; 53: 589-598.
141. Testa C, Nuti F, Hayek J, De Felice C, Chelli M, Rovero P et al. Di-(2-ethylhexyl) phthalate and autism spectrum disorders. ASN Neuro 2012; 4: 223-229.
142. Stein TP, Schluter MD, Steer RA, Ming X. Autism and phthalate metabolite glucuronidation. J Autism Dev Disord 2013; 43: 2677-2685.
143. Ashwood P, Schauer J, Pessah IN, Van de Water J. Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J Neuroimmunol 2009; 208: 130-135.
144. Archibeque-Engle SL, Tessari JD, Winn DT, Keefe TJ, Nett TM, Zheng T. Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. J Toxicol Environ Health 1997; 52: 285-293.
145. Jandacek RJ, Anderson N, Liu M, Zheng S, Yang Q, Tso P. Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene. Am J Physiol Gastrointest Liver Physiol 2005; 288: G292-G299.
146. Yu GW, Laseter J, Mylander C. Persistent organic pollutants in serum and several different fat compartments in humans. J Environ Public Health 2011; 2011: 417980.
147. Rusiecki JA, Matthews A, Sturgeon S, Sinha R, Pellizzari E, Zheng T et al. A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev 2005; 14: 1113-1124.
148. Ruggeri B, Sarkans U, Schumann G, Persico AM. Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 2013; 151: 181-186.
149. Eskenazi B, Huen K, Marks A, Harley KG, Bradman A, Barr DB et al. PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero. Environ Health Perspect 2010; 118: 1775-1781.
150. Pasca SP, Nemes B, Vlase L, Gagyi CE, Dronca E, Miu AC et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 2006; 78: 2244-2248.
151. Pasca SP, Dronca E, Nemes B, Kaucsar T, Endreffy E, Iftene F et al. Paraoxonase 1 activities and polymorphisms in autism spectrum disorders. J Cell Mol Med 2010; 14: 600-607.
152. Gaita L, Manzi B, Sacco R, Lintas C, Altieri L, Lombardi F et al. Decreased serum arylesterase activity in autism spectrum disorders. Psychiatry Res 2010; 180: 105-113.
153. D'Amelio M, Ricci I, Sacco R, Liu X, D'Agruma L, Muscarella LA et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 2005; 10: 1006-1016.
154. Serajee FJ, Nabi R, Zhong H, Huq M. Polymorphisms in xenobiotic metabolism genes and autism. J Child Neurol 2004; 19: 413-417.
155. Al-Yafee YA, Al-Ayadhi LY, Haq SH, El-Ansary AK. Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol 2011; 11: 139.
156. Buyske S, Williams TA, Mars AE, Stenroos ES, Ming SX, Wang R et al. Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism. BMC Genet 2006; 7: 8.
157. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 947-956.
158. Williams TA, Mars AE, Buyske SG, Stenroos ES, Wang R, Factura-Santiago MF et al. Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 2007; 161: 356-361.
159. Gundacker C, Komarnicki G, Jagiello P, Gencikova A, Dahmen N, Wittmann KJ et al. Glutathione-S-transferase polymorphism, metallothionein expression, and mercury levels among students in Austria. Sci Total Environ 2007; 385: 37-47.
160. Klautau-Guimarães MN, D'Ascenção R, Caldart FA, Grisolia CK, Souza JR, Barbosa AC et al. Analysis of genetic susceptibility to mercury contamination evaluated through molecular biomarkers in at-risk Amazon Amerindian populations. Genet Mol Biol 2005; 28: 827-832.
161. Westphal GA, Schnuch A, Schulz TG, Reich K, Aberer W, Brasch J et al. Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization. Int Arch Occup Environ Health 2000; 73: 384-388.
162. Tsai PC, Huang W, Lee YC, Chan SH, Guo YL. Genetic polymorphisms in CYP1A1 and GSTM1 predispose humans to PCBs/PCDFs-induced skin lesions. Chemosphere 2006; 63: 1410-1418.
163. Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004; 110: 598-604.
164. Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med 2012; 52: 2128-2141.
165. Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tancredi DJ et al. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 2011; 22: 476-485.
166. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 80: 1611-1617.
167. James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O et al. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 2009; 23: 2374-2383.
168. Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord 2012; 42: 367-377.
169. Rose S, Melnyk S, Savenka A, Hubanks A, Jernigan S, Cleves MA et al. The frequency of polymorphisms affecting lead and mercury toxicity among children with autism. Am J Biochem Biotech 2008; 4: 85-94.
170. Montenegro MF, Barbosa FJr, Sandrim VC, Gerlach RF, Tanus-Santos JE. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Arch Toxicol 2006; 80: 394-398.
171. Weuve J, Kelsey KT, Schwartz J, Bellinger D, Wright RO, Rajan P et al. Deltaaminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study. Occup Environ Med 2006; 63: 746-753.
172. Owens SE, Summar ML, Ryckman KK, Haines JL, Reiss S, Summar SR et al. Lack of association between autism and four heavy metal regulatory genes. Neurotoxicology 2011; 32: 769-775.
173. O'Reilly BA, Waring RH. Enzyme and sulphur oxidation deficiencies in autistic children with known food/chemical intolerances. J Orthomol Med 1993; 8: 198-200.
174. Waring RH, Ngong JM, Klovrza L, Green S, Sharp H. Biochemical parameters in autistic children. Dev Brain Dysfunct 1997; 10: 40-43.
175. Li Z, Dong T, Proschel C, Noble M. Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function. PLoS Biol 2007; 5: e35.
176. Shelton JF, Hertz-Picciotto I, Pessah IN. Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect 2012; 120: 944-951.
177. Vahter M, Akesson A, Liden C, Ceccatelli S, Berglund M. Gender differences in the disposition and toxicity of metals. Environ Res 2007; 104: 85-95.
178. Mocarelli P, Gerthoux PM, Ferrari E, Patterson DG Jr, Kieszak SM, Brambilla P et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 2000; 355: 1858-1863.
179. Hertz-Picciotto I, Jusko TA, Willman EJ, Baker RJ, Keller JA, Teplin SW et al. A cohort study of in utero polychlorinated biphenyl (PCB) exposures in relation to secondary sex ratio. Environ Health 2008; 7: 37.
180. Borras C, Gambini J, Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci 2007; 12: 1008-1013.
181. Lavoie JC, Chessex P. Gender and maturation affect glutathione status in human neonatal tissues. Free Radic Biol Med 1997; 23: 648-657.
182. Ballatori N, Clarkson TW. Dependence of biliary secretion of inorganic mercury on the biliary transport of glutathione. Biochem Pharmacol 1984; 33: 1093-1098.
183. Thomas DJ, Fisher HL, Sumler MR, Mushak P, Hall LL. Sexual differences in the excretion of organic and inorganic mercury by methyl mercury-treated rats. Environ Res 1987; 43: 203-216.
184. Muraoka Y, Itoh F. Sex difference of mercuric chloride-induced renal tubular necrosis in rats--from the aspect of sex differences in renal mercury concentration and sulfhydryl levels. J Toxicol Sci 1980; 5: 203-214.
185. Oliveira FR, Ferreira JR, dos Santos CM, Macedo LE, de Oliveira RB, Rodrigues JA et al. Estradiol reduces cumulative mercury and associated disturbances in the hypothalamus-pituitary axis of ovariectomized rats. Ecotoxicol Environ Saf 2006; 63: 488-493.
186. Llop S, Lopez-Espinosa MJ, Rebagliato M, Ballester F. Gender differences in the neurotoxicity of metals in children. Toxicology 2013; 311: 3-12.
187. Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M. How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicology 2008; 29: 190-201.
188. Ballatori N, Clarkson TW. Biliary transport of glutathione and methylmercury. Am J Physiol 1983; 244: G435-G441.
189. Pessah IN, Seegal RF, Lein PJ, LaSalle J, Yee BK, Van De Water J et al. Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology 2008; 29: 532-545.
190. Quattrocchi CC, Wannenes F, Persico AM, Ciafre SA, D'Arcangelo G, Farace MG et al. Reelin is a serine protease of the extracellular matrix. J Biol Chem 2002; 277: 303-309.
191. Serajee FJ, Zhong H, Mahbubul Huq AH. Association of Reelin gene polymorphisms with autism. Genomics 2006; 87: 75-83.
192. Fatemi SH, Stary JM, Halt AR, Realmuto GR. Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 2001; 31: 529-535.
193. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006; 29: 349-358.
194. Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/ inhibition in key neural systems. Genes Brain Behav 2003; 2: 255-267.
195. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001; 57: 1618-1628.
196. Kenet T, Froemke RC, Schreiner CE, Pessah IN, Merzenich MM. Perinatal exposure to a noncoplanar polychlorinated biphenyl alters tonotopy, receptive fields, and plasticity in rat primary auditory cortex. Proc Natl Acad Sci USA 2007; 104: 7646-7651.
197. Xu F, Farkas S, Kortbeek S, Zhang FX, Chen L, Zamponi GW et al. Mercuryinduced toxicity of rat cortical neurons is mediated through N-Methyl-DAspartate receptors. Mol Brain 2012; 5: 30.
198. Juarez BI, Martinez ML, Montante M, Dufour L, Garcia E, Jimenez-Capdeville ME. Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats. Neurotoxicol Teratol 2002; 24: 767-771.
199. Gafni J, Wong PW, Pessah IN. Non-coplanar 2, 2', 3, 5', 6-pentachlorobiphenyl (PCB 95) amplifies ionotropic glutamate receptor signaling in embryonic cerebellar granule neurons by a mechanism involving ryanodine receptors. Toxicol Sci 2004; 77: 72-82.
200. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002; 7: 302-310.
201. Serajee FJ, Zhong H, Nabi R, Huq AH. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 2003; 40: e42.
202. Buxbaum JD, Silverman JM, Smith CJ, Greenberg DA, Kilifarski M, Reichert J et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 2002; 7: 311-316.
203. Vincent JB, Horike SI, Choufani S, Paterson AD, Roberts W, Szatmari P et al. An inversion inv(4)(p12-p15.3) in autistic siblings implicates the 4p GABA receptor gene cluster. J Med Genet 2006; 43: 429-434.
204. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 2006; 103: 16834-16839.
205. Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004; 119: 1013-1026.
206. Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 2009; 46: 1-8.
207. Grandjean P. Individual susceptibility in occupational and environmental toxicology. Toxicol Lett 1995; 77: 105-108.
208. Weiss B, Bellinger DC. Social ecology of children's vulnerability to environmental pollutants. Environ Health Perspect 2006; 114: 1479-1485.
209. Filipek PA, Accardo PJ, Baranek GT, Cook EH Jr, Dawson G, Gordon B et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999; 29: 439-484.
210. Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL et al. Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988-2004. Pediatrics 2009; 123: e376-e385.
211. Bellinger DC. Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr 2008; 20: 172-177.
212. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in US children. Environ Health Perspect 2006; 114: 1904-1909.
213. Helt M, Kelley E, Kinsbourne M, Pandey J, Boorstein H, Herbert M et al. Can children with autism recover? If so, how? Neuropsychol Rev 2008; 18: 339-366.
214. Seidel S, Kreutzer R, Smith D, McNeel S, Gilliss D. Assessment of commercial laboratories performing hair mineral analysis. JAMA 2001; 285: 67-72.